Comments to FDA: CPSIA Share page: CHPA comments on the “Notice of Availability of Draft Guidance Regarding Which Children’s Products are Subject to the Requirements of CPSIA Section 108.” Download Document Issues: OTC Medicines Children's Cough and Cold Medicines Pediatrics Medicine Other Issues Research Related Posts Press Releases and Statements CHPA SVP of Regulatory & Scientific Affairs Delivers Remarks at FDA OMUFA Public Meeting Sep 28, 2023 Press Releases and Statements Citizen Petition Urges FTC to Immediately Withdraw Notice of Penalty Offenses Sent to Hundreds of Consumer Healthcare Companies Sep 15, 2023 Press Releases and Statements Statement Following the September 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) to Evaluate New Data Concerning the Efficacy of Oral PE Sep 12, 2023